Youwei Bi is currently the Director of QP2 Pharmacometrics at Merck, a position held since 2025. They previously served as a Pharmacometrics Team Leader at the FDA from 2021 to 2025, where they were a master reviewer with extensive experience in evaluating INDs, NDAs, and BLAs across various therapeutic areas, including oncology, immunology, and dermatology. Youwei holds a Doctor of Philosophy (Ph.D.) in Clinical Pharmaceutical Sciences and a Master's Degree in Biostatistics, both from the University of Iowa, as well as a Bachelor's degree in Pharmacy from Shanghai Jiao Tong University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices